Guizhou Sanli Pharmaceutical Co.,Ltd. (603439.SH) plans to acquire a 40% stake in its subsidiary, Sankang Partnership.

Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that it intends to acquire 40% of the equity of its controlling subsidiary Guizhou Sankang Enterprise Management Partnership Enterprise (Limited Partnership), held by Guizhou Health Agricultural Traditional Chinese Medicine Ingredients Industry Development Group Co., Ltd. (referred to as "Health Farm") for a transfer price of 40 million RMB, to be paid in cash.